What You Should Know: FIGS, Inc. (NYSE: FIGS), the direct-to-consumer healthcare apparel and lifestyle brand, and Eko Health, Inc. (“Eko”), a leading innovator in digital health technology for heart and lung disease detection, today announced the launch of the FIGS | Eko CORE 500TM Digital Stethoscope.The collaboration unites two companies that have reinvented two healthcare professionals’ mainstays — scrubs and stethoscopes — through new technology, modern design, and authentic
Read More
digital stethoscope
Nursing Facilities – A Medical Crisis in Need of a Prescription
Nursing facilities have evolved from rest homes to medical facilities over the last 20 years. Patients are sicker, older, have more medical comorbidities, and are frailer. They require more assistance with activities associated with daily living and have much greater rates of cognitive impairment. People over 85 are the most rapidly expanding demographic and the elderly segment of the American population is expected to double in 2030 from 2010. Even with a shift to providing higher-intensity
Read More
Eko Lands $2.7M NIH Grant to Train Pulmonary Hypertension AI
What You Should Know: - Eko, a digital health company applying machine learning in the fight against heart and lung disease, today announced that it was awarded a $2.7M Small Business Innovation Research (SBIR) Direct Phase II grant by the National Institutes of Health’s (NIH) Department of Health and Human Services (HHS). - The grant will fund the development of a machine learning algorithm that detects and stratifies pulmonary hypertension (PH) using phonocardiogram (PCG) and
Read More
Caregility and Eko Integrate to Address Gap in Telehealth
What You Should Know: - Caregility, an enterprise telehealth platform company, and Eko, the market leader in stethoscopes for telehealth, today announced an integration partnership. - Caregility’s cloud platform now seamlessly integrates with Eko’s smart stethoscopes and software, enabling users of Caregility’s iConsult application to perform high-quality auscultation (heart, lung, and other body sounds) on patients during a virtual physical exam. Addressing Virtual Care Gaps to Improve
Read More
Eko Launches Next Generation DUO ECG + Digital Stethoscope for Frontline Clinicians
What You Should Know: - Eko, a cardiopulmonary digital health company launches its next-generation Eko DUO, an FDA-cleared cardiac assessment tool that functions as an electrocardiogram (ECG) and digital stethoscope to detect early signs of heart disease and facilitate timely care and personalized disease management. - DUO is a pocket-sized cardiac examination system for clinicians used to detect early signs of heart disease and facilitate timely care for patients in and out of the clinic.
Read More
Eko Lands $65M to Expand AI-Powered Telehealth Platform for Virtual Pulmonary and Cardiac Exam
What You Should Know: - Cardiopulmonary digital health company Eko raises $65M in Series C funding to close the gap between virtual and in-person heart and lung care. - The latest round of funding will enable Eko to expand in-clinic use of its platform of telehealth and AI algorithms for disease screening and to launch a monitoring program for cardiopulmonary patients at home. Eko, a cardiopulmonary digital health company, today announced $65 million in Series C funding led by
Read More
3M and Eko Launches 3M Littmann® CORE Digital Stethoscope for Clinicians
What You Should Know: - 3M and Eko team up to launch 3M Littmann® CORE Digital Stethoscope to deliver a game-changing tool for clinicians as they assess, diagnose, and monitor their patients. - The new 3M Littmann CORE Digital Stethoscope offers clinicians access to both analog and digital auscultation options and connects to Eko’s software and AI algorithms* to help clinicians better interpret sounds and detect heart murmurs. 3M™ Littmann® Stethoscopes and Eko, today announced the
Read More
Eko Launches AI-Powered Telehealth Platform for Virtual Pulmonary and Cardiac Exam
What You Should Know: Eko launches first AI-Powered telehealth platform for virtual pulmonary and cardiac exams, providing clinicians with in-person level exam capabilities during video visits. Already deployed by more than 200 health systems for telehealth, platform goes beyond standard video conferencing to facilitate stethoscope audio, ECG live-streaming, and FDA-cleared identification of atrial fibrillation (AFib) and heart murmurs. Eko today announced Eko Telehealth, an
Read More
FDA Clears Eko’s AFib, Heart Murmur Detection Algorithms for AI-Powered Stethoscope
- StartX company, Eko, announced today that the FDA has cleared Eko’s AFib and heart murmur detection algorithms, making it the first AI-powered stethoscope to screen for serious heart conditions. - Eko’s algorithms alert clinicians to the presence of heart murmurs and atrial fibrillation (AFib) during the physical exam, converting the classic stethoscope into a powerful early detection tool. Eko, a digital health company applying artificial intelligence (AI) in the fight against heart disease,
Read More
FDA Breakthrough Status Granted for Heart Failure Algorithm by Eko
- Eko announced the FDA has granted “breakthrough status” for an algorithm that could provide an easily accessible screening test for heart failure during routine physical exams.- This designation is awarded to novel innovations that demonstrate the potential to address unmet medical needs for life-threatening or irreversibly debilitating diseases. - Heart failure is often left untreated until it’s too late due to costs, inaccessibility to echocardiogram testing, or misdiagnosis. With nearly six
Read More